Daxor Corp

NASDAQ:DXRUnited States

Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. It is also focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. It has several ongoing trials in the areas of heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.

Contact Information

Headquarters

SUITE 7120, 350 FIFTH AVENUENEW YORK, NY, United States 10118

Phone

212-244-0555

Fax

212-244-0806

Executives

Chairman of the Board, President, Chief Executive Officer

Michael Feldschuh

Chief Financial Officer, Chief Compliance Officer, Corporate Secretary

Robert Michel

Chief Scientific Officer, Director

Jonathan Feldschuh

Independent Director

Henry Cremisi

Independent Director

Caleb Desrosiers